Ozgul Muneyyirci-Delale

No ORCID on file · 7 papers in corpus · active 2003-2021

Study types

  • article 5
  • case-report 1
  • other 1

Condition tags

  • endometriosis 2
  • mesh:D004715 2
  • adenomyosis 2
  • dysmenorrhea 2
  • mesh:D004412 1
  • infertility 1
  • mesh:D017699 1
  • endometrioma 1
article 2021
F&S reports ·doi:10.1016/j.xfre.2021.05.004

OBJECTIVE: To determine if coexisting adenomyosis limits the efficacy of elagolix, an oral gonadotropin-releasing hormone antagonist, with hormonal add-back therapy in reducing heavy menstrual bleeding in women with uterine fibroids. DESIGN…

article 2012
International journal of women's health ·doi:10.2147/ijwh.s27819

PURPOSE: Evaluate the efficacy of norethindrone acetate in the resolution of symptoms and regression of recurrent endometrioma. PATIENTS AND METHODS: Retrospective chart review at SUNY Downstate Medical Center of patients with a history of …

article 2012
Pharmaceuticals (Basel, Switzerland) ·doi:10.3390/ph5101120

The role of norethindrone acetate (NA) in the management of adenomyosis was evaluated with a retrospective chart review of 28 premenopausal women between 27-49 years of age presenting with moderate to severe pelvic pain and bleeding. Bleedi…

article 2011
Medical hypotheses ·doi:10.1016/j.mehy.2011.10.008
case-report 2008
Complementary therapies in clinical practice ·doi:10.1016/j.ctcp.2008.01.002

BACKGROUND: Phytoestrogens have been thought to have favorable effects on women's health and perhaps in offsetting cancers. The possible adverse effects of phytoestrogens have not been evaluated. CASES: Abnormal uterine bleeding with endom…

other 2008
Fertility and sterility ·doi:10.1016/j.fertnstert.2008.05.002
article 2003
International journal of fertility and women's medicine

OBJECTIVE: To compare the breakthrough bleeding in endometriosis patients treated with Lupron-Depot alone, norethindrone acetate following Lupron-Depot, and norethindrone acetate alone. PATIENTS AND METHODS: 71 women with symptomatic surgic…